Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$374M |
| 2 |
AT&T
T
|
+$293M |
| 3 |
NVIDIA
NVDA
|
+$291M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$283M |
| 5 |
Williams Companies
WMB
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Lam Research
LRCX
|
+$351M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 4 |
Apple
AAPL
|
+$328M |
| 5 |
Boeing
BA
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.97% |
| 3 | Financials | 6.13% |
| 4 | Consumer Discretionary | 5.62% |
| 5 | Industrials | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEVA
5276
Aeva Technologies
AEVA
$1.93B
| $122K | ﹤0.01% |
20,432
+6,121
| +43% | +$49.1K |
|
|
SLN
5277
Silence Therapeutics
SLN
$543M
| $122K | ﹤0.01% |
19,684
+2,248
| +13% | +$26.5K |
|
|
ACHL
5278
DELISTED
Achilles Therapeutics
ACHL
| $122K | ﹤0.01% |
127,249
+45,494
| +56% | +$49.3K |
|
|
HLLY.WS
5279
CALL
DELISTED
Holley Inc Warrants
HLLY.WS
| $121K | ﹤0.01% |
333,333
| – | – |
|
5280
Lufax Holding
LU
$1.27B
| $121K | ﹤0.01% |
14,888
+10,187
| +217% | +$97.7K |
|
5281
AquaBounty Technologies
AQB
$5.82M
| $120K | ﹤0.01% |
10,054
-3,252
| -24% | -$52.3K |
|
|
FRGE
5282
DELISTED
Forge Global Holdings
FRGE
| $120K | ﹤0.01% |
+4,573
| New | +$124K |
|
|
LYRA
5283
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $120K | ﹤0.01% |
+1,162
| New | +$144K |
|
5284
Purple Innovation
PRPL
$39.3M
| $120K | ﹤0.01% |
+1,816
| New | +$203K |
|
5285
BARK
BARK
$83.6M
| $119K | ﹤0.01% |
+4,115
| New | +$130K |
|
5286
Amplify Alternative Harvest ETF
MJ
$103M
| $119K | ﹤0.01% |
2,805
-7,481
| -73% | -$371K |
|
5287
PUT
Nu Holdings
NU
$69B
| $119K | ﹤0.01% |
+25,000
| New | +$111K |
|
5288
Team
TISI
$77.5M
| $119K | ﹤0.01% |
21,746
-32,730
| -60% | -$249K |
|
5289
Alector
ALEC
$172M
| $118K | ﹤0.01% |
19,080
-31,422
| -62% | -$256K |
|
5290
Hagerty
HGTY
$1.35B
| $118K | ﹤0.01% |
13,514
-80,397
| -86% | -$733K |
|
5291
NexGen Energy
NXE
$6.97B
| $118K | ﹤0.01% |
30,807
-47,412
| -61% | -$204K |
|
|
OSI.WS
5292
CALL
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
| $118K | ﹤0.01% |
984,253
| – | – |
|
5293
Identive
INVE
$62.9M
| $117K | ﹤0.01% |
19,047
-8,066
| -30% | -$59.4K |
|
|
UWMC.WS
5294
CALL
DELISTED
UWM Holdings Warrants
UWMC.WS
| $117K | ﹤0.01% |
576,660
| – | – |
|
5295
Crexendo
CXDO
$218M
| $116K | ﹤0.01% |
72,097
+29,399
| +69% | +$54K |
|
5296
Equillium
EQ
$137M
| $116K | ﹤0.01% |
+158,778
| New | +$152K |
|
5297
ReposiTrak
TRAK
$155M
| $116K | ﹤0.01% |
18,335
-3,496
| -16% | -$20.8K |
|
5298
Vivani Medical
VANI
$120M
| $116K | ﹤0.01% |
115,768
-22,564
| -16% | -$25.1K |
|
|
LUMO
5299
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $116K | ﹤0.01% |
34,342
+14,305
| +71% | +$50.1K |
|
5300
Momentus
MNTS
$84.2M
| $115K | ﹤0.01% |
16
+11
| +220% | +$111K |
|
Similar funds
Millennium Management's Q1 2023 Portfolio in Review
As of Q1 2023, Millennium Management held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Millennium Management withdrew a net $18.1B in Q1 2023, closing 1,209 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.2% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Millennium Management opened a new position in Warner Bros worth $96.9M.
- Millennium Management's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
- Millennium Management added most to Linde in Q1 2023, an estimated $374M increase.
- Millennium Management's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
- Millennium Management fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
- Millennium Management's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
- Millennium Management opened 987 new positions and closed 1,209 in Q1 2023.
- Millennium Management's portfolio value fell 3.5% quarter-over-quarter to $174B.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.